FDA Drug Recalls

Recalls / Class II

Class IID-1831-2019

Product

Clear Eyes Maximum Redness Relief Club Pack Display; each display contains 18 3-Pack bottles (UPC 6 78112 10859 6) of Clear eyes MAXIMUM REDNESS RELIEF (Glycerin 0.5%, Naphazoline hydrochloride 0.03%) eye drops, 0.5 FL OZ (15 mL) bottle, (UPC 6 78112 66577 8); Distributed by Medtech Products Inc., Tarrytown, NY 10591, A Prestige Brands Company.

Affected lot / code info
Lot #: Q16322M1, Q16323M1, Q16323M2, Q16326M1, Exp 08/19; lot and expiry for individual products within this display are captured in each individual product Code Information

Why it was recalled

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Recalling firm

Firm
Medtech Products, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
660 White Plains Rd Ste 250, N/A, Tarrytown, New York 10591-5171

Distribution

Quantity
17,316 bottles
Distribution pattern
Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.

Timeline

Recall initiated
2019-07-26
FDA classified
2019-08-16
Posted by FDA
2019-08-28
Terminated
2021-03-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1831-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls